Clinical Trial Update: Special Use-results Surveillance on Long Term Use of Sogroya® in Children With Short Stature Due to Growth Hormone Deficiency Where Epiphysial Discs Are Not Closed

View source ↗

Summary

A special-use surveillance trial update reports ongoing data on the long-term safety of Sogroya in pediatric patients with growth hormone deficiency who have no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency in Children

Drugs mentioned

• Sogroya (somapacitan)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Hormone Deficiency in Children | Status: ENROLLING_BY_INVITATION